mild, moderate Novel Coronavirus Infectious Disease (COVID-19)

DBCOND0134176InfectionsRespiratory Tract Diseases

mild, moderate Novel Coronavirus Infectious Disease (COVID-19) is the indication for 7 drugs in DrugBank. It is covered by 11 curated, structured indications.

Also known as
Mild-to-moderate COVID-19 · Mild to Moderate COVID-19
Classified under
Indicated drugs

What you can answer from here — as of October 23, 2026

7Indicated drugsWith each drug's targets and mechanism
Listed above
11Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for mild, moderate Novel Coronavirus Infectious Disease (COVID-19) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In